| |
|
|
|
Xtalks, online
2023 -10-13
Regulated digital polymerase chain reaction (dPCR), quantitative polymerase chain reaction (qPCR) and reverse transcriptase quantitative polymerase chain reaction (qRT-PCR) are extensively utilized to support biodistribution, vector shedding, gene expression, chimeric antigen receptor (CAR) T cell therapy and oncolytic viral bioanalytical studies.
In this presentation, the featured speakers will review the advantages and disadvantages of dPCR, qPCR and qRT-PCR as it relates to vaccine and biotherapeutic research. They will also discuss the current method development and method validation best practices, context of use and level of regulatory compliance required to support bioanalysis in pre-clinical and clinical settings.
Join this informative webinar to gain insights into the best use of PCR methods in vaccine and biotherapeutic research in pre-clinical and clinical development.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Manisha R. Diaz, PhD, Associate Director of Research and Development, Eurofins Viracor BioPharma Services Deepak Tomar, PhD, Senior Scientific Lab Lead, Eurofins Bioanalytical Services Erik Jerks, PhD, Director of Bioanalytical Services, Eurofins Bioanalytical Services
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -10-13
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|